Peer Review History

Original SubmissionJuly 12, 2022
Decision Letter - Abram L. Wagner, Editor

PGPH-D-22-01112

Estimates of the number and distribution of zero-dose and under-immunised children across remote-rural, urban, and conflict-affected settings in low and middle-income countries

PLOS Global Public Health

Dear Dr. Wigley,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers have very minimal feedback. Please respond to the minor issues below. Note that one reviewer mentioned your abstract. Although PLOS Global Public Health does not use structured abstract headings, it might be worth adding a bit more methods into the abstract in your response to that reviewer's comment.

Please submit your revised manuscript by Sep 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Abram L. Wagner, PhD, MPH

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please update the completed 'Competing Interests' statement. Please declare all competing interests beginning with the statement “I have read the journal's policy and the authors of this manuscript have the following competing interests:”.

2. Please amend your online detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

a. State the initials, alongside each funding source, of each author to receive each grant.

b. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

3. Please provide separate figure files in .tif or .eps format only and ensure that all files are under our size limit of 10MB.

For more information about how to convert your figure files please see our guidelines: https://journals.plos.org/globalpublichealth/s/figures

4. We have noticed that you have a list of Supporting Information legends in your manuscript. However, there are no corresponding files uploaded to the submission. Please upload them as separate files with the item type 'Supporting Information'.

5. All figures and supporting information files will be published under the Creative Commons Attribution License (creativecommons.org/licenses/by/4.0/). Authors retain ownership of the copyright for their article and are responsible for third-party content used in the article. 

Figures 1, 2, 3, and 5: please (a) provide a direct link to the base layer of the map used and ensure this is also included in the figure legend; (b) provide a link to the terms of use / license information for the base layer. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC-BY 4.0 license. 

If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC-BY 4.0 license.

Please note that the following CC BY licenses are compatible with PLOS license: CC BY 4.0, CC BY 2.0 and CC BY 3.0, meanwhile such licenses as CC BY-ND 3.0 and others are not compatible due to additional restrictions. 

If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps: 

* U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov

* PlaniGlobe - All maps are published under a Creative Commons license so please cite “PlaniGlobe, http://www.planiglobe.com, CC BY 2.0” in the image credit after the caption. (http://www.planiglobe.com/?lang=enl) 

* Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/)

Please upload any written confirmation as an 'Other' file type. It must clarify that the copyright holder understands and agrees to the terms of the CC BY 4.0 license; general permission forms that do not specify permission to publish under the CC BY 4.0 will not be accepted. Note that uploading an email confirmation is acceptable.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

Reviewer #4: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I don't know

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Summary:

This study uses geospatial datasets to map and estimate global and regional gaps in under one vaccination status with a focus on settings expected to be high risk for un- or under-vaccinated children: remote-rural, urban, and conflict affected areas. This study found that although many of the un- and under-vaccinated are in these high risk areas, about 60% live outside of those settings not classified as remote (rural non-remote), pointing to the need for more targeted strategies at the national and regional level to close vaccination gaps.

Review:

This is a high caliber, well-written and impactful study. This study’s approach is both novel and practical, using multiple geospatial datasets to drill down to assess vaccination status in settings hypothesized to be high risk. The methods are sound and clearly written, including the acknowledgment of limitations in slum estimates. The results are well-presented with easy to follow figures, providing key estimates and illustrating vaccination gaps overall, remote-rural, urban, conflict areas, and rural non-remote. The discussion interprets the results well, with a clear and concise summary of the key findings: although many of the vaccination gaps exist in the expected high-risk settings, there is great variability in vaccination coverage within countries. The discussion also provides important recommendations and strategies to improve vaccination coverage. Overall, this study adds scientific value with detailed estimates of vaccination gaps based on geospatial data, uncovers gaps in unexpected settings, and shows how this geospatial data approach can be used to improve vaccination coverage in targeted settings.

Reviewer #2: Thank you, authors, for the opportunity to review your work. The work is very interesting and adds detailed input to existing knowledge. I just have a few concerns highlighted below;

Line 25 …….estimate…. replace with ….estimated….

Line 28 ….. we find… replace with ………we found…..

Line 29 delete We estimate…. It should read as Of the…….

Lines 57-61 is just one sentence consider breaking it into 2 or 3 sentences

Overall, the article was well written. I would just advise the authors to revise some of the long sentences and make them shorter as it is easier to engage with shorter sentences than long sentences. Well done.

Reviewer #3: Abstract

Redesign the entire abstract following the IMRaD structure. Start from the general to the specific in the introduction. The methodology should also be included in the summary. Clearly state your results (rephrasing). The conclusion must be well separated and must support the results of the work.

Results

Put the titles of the tables at the top

Remove the percentage symbol inside table 1 by adopting for example n(%). This form of presentation is easy to understand. In the header of table 1, put for example DTP1 (N=14,030,486) and so on for the other variables in the header.

Review the references. I noticed that the numbers are missing. Also review the pages.

For example, on line 497 for reference 33, it is ............26(12):1-4.

Reviewer #4: Title:

Remove one 'and' and just use comma. Hence the title should be: 'Estimates of the number, distribution of zero-dose and under-immunised children

across remote-rural, urban, and conflict-affected settings in low and middle-income

countries

Methods and results:

only Univariate level i.e,. propotions have been calculated. Can you go farther to the level of bivariate and multivariate leves ie. to find out Asociations of the factors?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Nicolas Hamondji AMEGAN, MPH

Reviewer #4: Yes: Dr. Joseph C. Hokororo

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Abram L. Wagner, Editor

Estimates of the number and distribution of zero-dose and under-immunised children across remote-rural, urban, and conflict-affected settings in low and middle-income countries

PGPH-D-22-01112R1

Dear Ms Wigley,

We are pleased to inform you that your manuscript 'Estimates of the number and distribution of zero-dose and under-immunised children across remote-rural, urban, and conflict-affected settings in low and middle-income countries' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Abram L. Wagner, PhD, MPH

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .